TITLE

Treatment of Gross Obesity by Jejunal Bypass

AUTHOR(S)
Gazet, J-C.; Pilkington, T. R. E.; Kalucy, R. S.; Crisp, A. H.; Day, Sally
PUB. DATE
November 1974
SOURCE
British Medical Journal;11/9/1974, Vol. 4 Issue 5940, p311
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64112187

 

Related Articles

  • Is Systemic Inflammation Not Involved in Endoscopic Duodenal-Jejunal Bypass Liner-Induced Diabetes Remission? Wu, Cheng-I; Lee, Wei-Jei; Chen, Chih-Yen // Obesity Surgery;Nov2014, Vol. 24 Issue 11, p2001 

    A letter to the editors is presented "Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetes," by C. de Jonge and colleagues in the 2014 issue.

  • Diagnose Nutrient Deficiencies Following Bariatric Surgery. Kohlstadt, Ingrid // Townsend Letter;Jan2008, Issue 294, p110 

    The article discusses the restrictive and malabsorptive procedures in bariatric surgeries in the treatment on nutritional disorders and obesity. Restrictive procedure is limited to the size of the stomach including gastroplasty and roux-en y gastric bypass. Malabsorptive procedure shortens and...

  • Intravascular hemolysis, thrombocytopenia, leukopenia, and circulating immune complexes after jejunal-ileal bypass surgery. Moake, J.L.; Kageler, W.V.; Cimo, P.L.; Blakely, R.W.; Rossen, R.D.; Haesse, W. // Annals of Internal Medicine;May77, Vol. 86 Issue 5, p576 

    Two years after jejunal-ileal bypass surgery for obesity, a 25-year-old man developed intravascular hemolysis, thrombocytopenia, and neutropenia. The patient's erythrocytes were coated with complement components (C4/C3) and his serum induced complement-dependent immune lysis of...

  • Duodenal bypass for the treatment of obesity and T2D. Taheri, Shahrad // Diabetes Digest;2013, Vol. 12 Issue 3, p126 

    The article discusses the utilization of duodenal-jejunal bypass liner (DJBL) surgery for the treatment of obese individuals with type 2 diabetes (T2D). It elaborates several factors of post bariatic surgery including changes in body fat distribution, alteration in bile acids and weight loss. It...

  • In obesity with type 2 diabetes, duodenal-jejunal bypass liners improved weight loss and HbA1c during treatment. Cheskin, Lawrence J.; Mullin, Gerard E. // Annals of Internal Medicine;2/17/2015, Vol. 162 Issue 4, pJC9 

    The article discusses the study "The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial" by P. Koehestanie and colleagues and published in a 2014 issue of the periodical "Annals of Surgery". Topics discussed...

  • Giant jejunal ulcers after Roux-en-Y gastric bypass. Ruutiainen, Alexander T.; Levine, Marc S.; Williams, Noel N. // Abdominal Imaging;Sep/Oct2008, Vol. 33 Issue 5, p575 

    We describe the clinical and radiographic findings in two patients who developed giant, intractable ulcers in the jejunal Roux limb after gastric bypass surgery, most likely secondary to chronic jejunal ischemia. The diagnosis of such ulcers is important because of the need for aggressive...

  • Intestinal Bypass Operation as a Treatment for Obesity. Bray, George A.; Barry, Ralph E.; Benfield, John R.; Castelnuovo-Tedesco, Pietro; Drenick, Ernst J.; Passaro, Edward // Annals of Internal Medicine;Jul76, Vol. 85 Issue 1, p97 

    Discusses the utilization of intestinal bypass operation as a method for treating obesity. Information on intestinal bypass surgery; Criteria and indications for intestinal bypass treatment of obese patients; Psychological effects of the surgery.

  • Duodenal-jejunal bypass liner improved glycemic control, weight. Altersitz, Katrina; Costa, Samantha; Foster, Melissa // Endocrine Today;Oct2013, Vol. 11 Issue 10, p42 

    The article discusses the results of a study which showed the safety and effectiveness of duodenal-jejunal bypass liner device for the management of obese patients with type 2 diabetes, referencing a research by Julian Teare of the Imperial College of Healthcare National Health Service (NHS) Trust.

  • The Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes Mellitus and/or Obesity: a Systematic Review. Zechmeister-Koss, Ingrid; Huić, Mirjana; Fischer, Stefan // Obesity Surgery;Feb2014, Vol. 24 Issue 2, p310 

    This systematic literature review applies the GRADE approach to evaluate the efficacy and safety of the duodenal-jejunal bypass liner (DJBL) for the treatment of (a) patients with obesity ≥ grade II (with comorbidities) and (b) patients with type 2 diabetes mellitus + obesity ≥ grade...

  • Explanations for weight loss after ileojejunal bypass in gross obesity. Pilkington, T.R.E.; Gazet, J.C.; Ang, Lisa; Kalucy, R.S.; Crisp, A.H.; Day, Sally // British Medical Journal;6/19/1976, Vol. 1 Issue 6024, p1504 

    Explains weight loss after ileojejunal bypass in gross obesity. Measurement of calorie lost; Examination of malabsorption condition; Contributions of dietary restrictions and increased food intake.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics